Nutex Health (NUTX) Gross Profit (2010 - 2026)

Nutex Health has disclosed Gross Profit across 17 years of filings, most recently posting $91.7 million for Q1 2026.

• Gross Profit for Q1 2026 came in at $91.7 million, down 22.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $417.7 million (up 37.19% YoY), and the FY2025 annual result was $444.3 million, up 126.37% from the prior year.
• Gross Profit came in at $91.7 million for Q1 2026 at Nutex Health, up from $46.1 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $154.9 million in Q3 2025 to a low of -$26.5 million in Q3 2022.
• The 5-year median for Gross Profit is $21.9 million (2024), against an average of $46.1 million.
• Peak annual rise in Gross Profit reached 8290.22% in 2022, while the deepest fall reached 134.82% in 2022.
• Nutex Health's Gross Profit stood at $530324.0 in 2022, then jumped by 2391.55% to $13.2 million in 2023, then surged by 971.84% to $141.6 million in 2024, then sank by 67.42% to $46.1 million in 2025, then soared by 98.82% to $91.7 million in 2026.
• The last three Gross Profit figures came in at $91.7 million (Q1 2026), $46.1 million (Q4 2025), and $154.9 million (Q3 2025), per Business Quant data.